We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.33%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,055
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Organon & Co
OGN
$3.58B
| – | – |
-10,884
| Closed | -$255K |
|
3252
VanEck Oil Services ETF
OIH
$1.95B
| – | – |
-3,000
| Closed | -$633K |
|
|
3253
PUT
VanEck Oil Services ETF
OIH
$1.95B
| – | – |
-1,500
| Closed | -$315K |
|
3254
Oceaneering
OII
$5.09B
| – | – |
-99,155
| Closed | -$790K |
|
3255
Oneok
OKE
$56.9B
| – | – |
-9,000
| Closed | -$461K |
|
3256
Outset Medical
OM
$91.4M
| – | – |
-12,552
| Closed | -$3M |
|
3257
Omnicom Group
OMC
$23.2B
| – | – |
-230,939
| Closed | -$14.6M |
|
|
ACH
3258
Accendra Health
ACH
$107M
| – | – |
-143,607
| Closed | -$3.46M |
|
3259
OneMedNet
ONMD
$37.6M
| – | – |
-28,754
| Closed | -$298K |
|
3260
OP Bancorp
OPBK
$233M
| – | – |
-59,048
| Closed | -$656K |
|
3261
Syntec Optics
OPTX
$305M
| – | – |
-501,831
| Closed | -$5.06M |
|
3262
Organogenesis Holdings
ORGO
$239M
| – | – |
-29,233
| Closed | -$95K |
|
3263
O'Reilly Automotive
ORLY
$75.3B
| – | – |
-211,080
| Closed | -$9.9M |
|
3264
OneSpan
OSPN
$603M
| – | – |
-92,821
| Closed | -$799K |
|
3265
Open Text
OTEX
$5.99B
| – | – |
-31,359
| Closed | -$829K |
|
|
OTLY
3266
Oatly Group
OTLY
$419M
| – | – |
-12,648
| Closed | -$666K |
|
3267
Oxford Industries
OXM
$556M
| – | – |
-130,150
| Closed | -$11.7M |
|
3268
Phibro Animal Health
PAHC
$1.39B
| – | – |
-28,569
| Closed | -$379K |
|
3269
Pangaea Logistics
PANL
$479M
| – | – |
-29,236
| Closed | -$135K |
|
3270
Passage Bio
PASG
$13.9M
| – | – |
-9,683
| Closed | -$242K |
|
3271
UiPath
PATH
$8.08B
| – | – |
-183,557
| Closed | -$2.31M |
|
3272
Payoneer
PAYO
$2.4B
| – | – |
-2,095,450
| Closed | -$12.7M |
|
3273
PCB Bancorp
PCB
$387M
| – | – |
-44,745
| Closed | -$807K |
|
|
PCH
3274
DELISTED
PotlatchDeltic
PCH
| – | – |
-35,501
| Closed | -$1.46M |
|
3275
Penumbra
PEN
$12.8B
| – | – |
-13,180
| Closed | -$2.5M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,055 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,055 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.